GWGuido H. Wabnitz

Guido H. Wabnitz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Guido H. Wabnitz has a total of 122 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    From destructive inflammation to redox-governed reparative immunity

    by Guido Wabnitz, Jörg Flemmig, Paiboon Maraprygsavan, Friedrich-Wilhelm Kühne

  • Open Access

    Mrgpra2+ neutrophils stand guard in the infected bone marrow

    by Guido Wabnitz

  • Open Access

    Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

    by Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, et al.

    Objective: To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab. Methods: In this prospective, exploratory real‐world study CH50 and AH50, eculizumab and ravulizumab blood levels were assessed in patients with acetylcholine‐receptor‐antibody (AChR‐ab) positive gMG. Patients were either pretreated with eculizumab or C5‐inhibitor naïve. Samples were collected before the next infusion (end‐of‐dose). Laboratory data were correlated with patient‐reported subjective duration of the ravulizumab effect. Results: Overall, 61 patients were enrolled. At the end of their respective dosing interval, median AH50 levels were more strongly suppressed with eculizumab than with ravulizumab (1% [0%–2%] versus 5% [3%–9%]; Cohen's d 2.2 [95% CI 1.5–2.8]). Patients who discontinued ravulizumab due to insufficient effects ( n = 19; 33%) had higher median AH50 levels than those who continued (7% [4%–13%] versus 5% [3%–8%]; Cohen's d −0.9 [95% CI −1.3 to −0.4]). In 81% ( n = 46) of patients, the therapeutic effect of ravulizumab diminished before the subsequent infusion after the standard 8‐week interval. Higher AH50 levels were correlated with earlier symptom recurrence. Interpretation: Our results indicate potential differences in the ability of eculizumab and ravulizumab to suppress complement pathway activity through their respective dosing intervals. Additionally, higher AH50 levels might be a potential biomarker to predict poor therapy response and faster wearing off of ravulizumab's effect. However, these findings need to be validated in large multicenter studies.


  • Open Access

    Accurate, fast and memory efficient quantification of immune cell phenotypes in cytometry using machine learning

    by Tarik Exner, Nicolaj S. Hackert, Frederic Pohl, Goerkem Osmanusta, Fee Schmidt, Hanns-Martin Lorenz, Guido Wabnitz, Georg Schett, Frederik Graw, Joerg Henes, et al.

    To achieve accurate and reproducible cytometry data analysis, we benchmarked 19 machine learning algorithms for supervised and unsupervised cell classification. The underlying data encompassed 138 million cells from seven independent datasets including conventional flow cytometry, spectral flow cytometry and mass cytometry. We found that tree-based classifiers and in particular Decision Trees, outperformed other approaches in classification accuracy, speed and memory use. High accuracy was achieved even for cell populations rarer than 1% using decision trees. We validated our decision tree-based approach in a clinical setting using diagnostic blood T cell phenotyping of 107 patients. Automatic quantification of CD4 helper T cell phenotypes achieved 99 % accuracy compared to manual expert assessment. Finally, we combined automated data transformation, supervised and unsupervised gating, an application program interface and a user-friendly desktop-application into FACSPy and FACSPyUI, a fast and scalable open-source toolbox for the analysis and visualization of cytometry data.

  • Open Access

    Human and mouse neutrophils share core transcriptional programs in both homeostatic and inflamed contexts

    by Nicolaj S. Hackert, Felix A. Radtke, Tarik Exner, Hanns-Martin Lorenz, Carsten Müller-Tidow, Peter A. Nigrovic, Guido Wabnitz, Ricardo Grieshaber-Bouyer

    Neutrophils are frequently studied in mouse models, but the extent to which findings translate to humans remains poorly defined. In an integrative analysis of 11 mouse and 13 human datasets, we find a strong correlation of neutrophil gene expression across species. In inflammation, neutrophils display substantial transcriptional diversity but share a core inflammation program. This program includes genes encoding IL-1 family members, CD14, IL-4R, CD69, and PD-L1. Chromatin accessibility of core inflammation genes increases in blood compared to bone marrow and further in tissue. Transcription factor enrichment analysis implicates members of the NF-κB family and AP-1 complex as important drivers, and HoxB8 neutrophils with JunB knockout show a reduced expression of core inflammation genes in resting and activated cells. In independent single-cell validation data, neutrophil activation by type I or type II interferon, G-CSF, and E. coli leads to upregulation in core inflammation genes. In COVID-19 patients, higher expression of core inflammation genes in neutrophils is associated with more severe disease. In vitro treatment with GM-CSF, LPS, and type II interferon induces surface protein upregulation of core inflammation members. Together, we demonstrate transcriptional conservation in neutrophils in homeostasis and identify a core inflammation program shared across heterogeneous inflammatory conditions.


  • Open Access

    Distinct Functional States of Neutrophils by Actin Disassembly and NF-kB/STAT3 Signaling

    by Niko Heineken, Jan-Christoph Schumacher, Tarik Exner, Friederike S. Neuenfeldt, Jüri Habicht, Franz Kahlich, Hadrian Platzer, Uta Merle, Tobias Renkawitz, Yvonne Samstag, et al.

    Polymorphonuclear neutrophils (PMNs) can differentiate into distinct states, which can either exacerbate or resolve inflammation. Our study shows that mice challenged with TLR agonists exhibited PMN differentiation along two major paths characterized by the expression of CCR5 or PD-L1. Similar differentiation was observed in the blood of severe COVID-19 patients and the synovial fluid of osteoarthritis patients. Prolonged in vitro priming of human PMNs modeled the differentiation paths. Actin disassembly favored CCR5 upregulation, while NF-kB activation stabilized the actin cytoskeleton and suppressed the development of CCR5 + PMNs. Additionally, PD-L1 upregulation was triggered by STAT3 signaling and NF-kB activation. Functionally, CCR5 expressing PMNs were pro-NETotic, while PD-L1 + PMNs showed immunosuppressive functions by inhibiting T cell proliferation via PD1. Together, PMN differentiation depended on the priming conditions, and the balance between actin disassembly and NF-kB/STAT3 activation translated the present micro-milieu into phenotypic and functional diversification of PMNs. Synopsis: Neutrophils underwent phenotypical and functional diversification both in vivo and in vitro . Actin disassembly led to the generation of CCR5 high neutrophils with increased spontaneous NETosis, whereas NF-kB and STAT3 induced PD-L1 expression with T-cell suppressive properties as a deviation from the default pathway. PMN of mice challenged with TLR agonists develop two distinct phenotypes, CCR5 high and PD-L1 high . CCR5 and PD-L1-defined neutrophil phenotypes were found in blood of patients with severe COVID-19 and in the synovial fluid of osteoarthritis patients. In vitro priming induced a similar bifurcation of PMN phenotypes marked by either CCR5 or PD-L1. Actin disassembly preceded canonical development of CCR5 + PMN. NF-kB halted actin disassembly by LPL regulation. During neutrophil priming, STAT3 aided NF-kB in the expression of PD-L1. Graphical

  • Open Access

    Human and murine neutrophils share core transcriptional programs in both homeostatic and inflamed contexts

    by Nicolaj S. Hackert, Felix A. Radtke, Tarik Exner, Hanns-Martin Lorenz, Carsten Müller-Tidow, Peter A. Nigrovic, Guido Wabnitz, Ricardo Grieshaber-Bouyer

    Neutrophils are frequently studied in murine models, but the extent to which findings translate to humans remains poorly defined. Here, we performed an integrative transcriptomic analysis of 11 murine and 13 human datasets. In homeostasis, neutrophils exhibited the highest number of lineage-specific genes and the greatest degree of correlated expression among genes with one-to-one orthologs ( r = 0.79, P < 2.2 × 10 −16 ) compared to other leukocytes. In inflammation, neutrophils displayed considerable transcriptional diversity, but shared a core inflammation program across a broad range of conditions which was conserved between species. This core program included genes encoding IL-1 family members, CD14, IL-4R, CD69 and PD-L1. Chromatin accessibility of core inflammation genes increased significantly in blood compared to bone marrow and further with migration from blood to tissue. Transcription factor enrichment analysis nominated members of the NF-κB family and AP-1 complex as important drivers of the core inflammation program, and HoxB8 neutrophils with JUNB knockout showed a significantly reduced expression of core inflammation genes at baseline and upon stimulation. In vitro perturbations confirmed surface protein upregulation of core inflammation members in both species. Together, we demonstrate substantial transcriptional conservation in neutrophils in homeostasis and identify a core inflammation program conserved across species. This systems biology approach can be leveraged to improve transitions between the murine and human context. Key Points: The transcriptome of resting neutrophils is substantially conserved between humans and mice A core inflammation program in neutrophils is shared across a broad range of conditions and conserved across humans and mice Graphical


  • Open Access

    Inflammation induces pro-NETotic neutrophils via TNFR2 signaling

    by Friederike Neuenfeldt, Jan Christoph Schumacher, Ricardo Grieshaber-Bouyer, Jüri Habicht, Jutta Schröder-Braunstein, Annika Gauss, Uta Merle, Beate Niesler, Niko Heineken, Alexander Dalpke, et al.


  • Open Access

    Inflammation induces pro-NETotic neutrophils via TNFR2 signaling

    by Friederike Neuenfeldt, Jan Christoph Schumacher, Ricardo Grieshaber-Bouyer, Jüri Habicht, Jutta Schröder-Braunstein, Annika Gauss, Beate Niesler, Niko Heineken, Alexander Dalpke, Matthias M. Gaida, et al.

    Cytokines released during chronic inflammatory diseases induce pro-inflammatory properties in polymorphonuclear neutrophils (PMN). Here we show that in vitro cytokine treatment leads to the development of a subgroup of human PMN expressing CCR5, termed CCR5 + cytokine-induced PMN (CCR5 + cPMN). Auto/paracrine TNF signaling increases intracellular neutrophil elastase (ELANE) abundance and induces NETosis in CCR5 + cPMN. Triggering of CCR5 amplifies NETosis. Membranous TNF (mTNF) outside-in signaling induces the formation of reactive oxygen species, a known activator of NETosis. In vivo , we find an increased number of CCR5 + cPMN in the peripheral blood and inflamed lamina propria of patients with ulcerative colitis (UC) but not Crohn’s disease (CD). Notably, failure of anti-TNF therapy is associated with higher frequencies of CCR5 + cPMN. In conclusion, we identify a phenotype of pro-NETotic, CCR5 positive PMN present in inflamed tissue in vivo and inducible in vitro . These cells may reflect an important component of tissue damage during chronic inflammation and could be of diagnostic value.